The European Medicines Agency has recommended doctors not to prescribe rimonabant (also known as Acomplia), a well known anti-obesity drug.
According to EMEA, the drug can alarmingly increase the risk of serious psychiatric problems and even suicides.
As the patients who are at risk cannot be identified that’s why marketing of the drug must be suspended, the […]















































